BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 4949165)

  • 1. Some clinical observations on the treatment with L-asparaginase of the acute leukemias.
    Marmont AM; Damasio EE
    Recent Results Cancer Res; 1970; 33():296-315. PubMed ID: 4949165
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of leukemias in man by L-asparaginase.
    Oettgen HF; Old LJ; Boyse EA; Campbell HA; Philips FS; Clarkson BD; Tallal L; Leeper RD; Schwartz MK; Kim JH
    Cancer Res; 1967 Dec; 27(12):2619-31. PubMed ID: 5237354
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical experience with L-asparaginase.
    Hamilton-Fairley G; Malpas JS; Galton DA
    Recent Results Cancer Res; 1970; 33():257-62. PubMed ID: 4949164
    [No Abstract]   [Full Text] [Related]  

  • 4. Result of a cooperative study with L-asparaginase in human leukemias. Report of the section "oncology" of the Paul-Ehrlich-Society for Chemotherapy.
    Gerhartz H; Begemann H
    Recent Results Cancer Res; 1970; 33():244-56. PubMed ID: 5292719
    [No Abstract]   [Full Text] [Related]  

  • 5. The place of the L-asparaginase in the treatment of acute leukemias.
    Mathé G; Amiel JL; Clarysse A; Hayat M; Schwarzenberg L
    Recent Results Cancer Res; 1970; 33():278-87. PubMed ID: 4403337
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical results of treatment with E. coli L-asparaginase in adults with leukemia, lymphoma, and solid tumors.
    Clarkson B; Krakoff I; Burchenal J; Karnofsky D; Golbey R; Dowling M; Oettgen H; Lipton A
    Cancer; 1970 Feb; 25(2):279-305. PubMed ID: 4905154
    [No Abstract]   [Full Text] [Related]  

  • 7. [First results of the treatment of acute leukemia with L-asparaginase].
    Marmont A; Damasio E; Bordo D; Fazio F; Gori E; Rossi F
    Haematologica; 1970; 55(9):593-6. PubMed ID: 4996527
    [No Abstract]   [Full Text] [Related]  

  • 8. A summary of the clinical status of asparaginase.
    Burchenal JH
    Recent Results Cancer Res; 1970; 33():350-4. PubMed ID: 5292724
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapy of leukemia in USA. 2. L asparaginase in leukemia].
    Böttiger LE
    Lakartidningen; 1969 Jan; 66(5):455-60. PubMed ID: 5254602
    [No Abstract]   [Full Text] [Related]  

  • 10. L-asparaginase: therapeutic and toxic effects in patients with neoplastic disease.
    Haskell CM; Canellos GP; Leventhal BG; Carbone PP; Block JB; Serpick AA; Selawry OS
    N Engl J Med; 1969 Nov; 281(19):1028-34. PubMed ID: 4898857
    [No Abstract]   [Full Text] [Related]  

  • 11. Dysmetabolic and neurological complications in leukemia patients treated with L-asparaginase.
    Storti E; Quaglino D
    Recent Results Cancer Res; 1970; 33():344-9. PubMed ID: 5292723
    [No Abstract]   [Full Text] [Related]  

  • 12. L-asparaginase in treatment of acute leukaemia and lymphosarcoma.
    Beard ME; Crowther D; Galton DA; Guyer RJ; Fairley GH; Kay HE; Knapton PJ; Malpas JS; Scott RB
    Br Med J; 1970 Jan; 1(5690):191-5. PubMed ID: 4904933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Preliminary results of the clinical study of a Soviet--produced L-asparaginase from E. coli].
    Kondrat'eva NA; Lorie IlI ; Kruglova GV; Vorob'ev AI; Koshel' IV
    Antibiotiki; 1977 Sep; 22(9):852-7. PubMed ID: 334060
    [No Abstract]   [Full Text] [Related]  

  • 14. [Asparaginase in the treatment of acute leukemias (author's transl)].
    de Carvalho RI; Durate RC; França Rde B; Rocha OS
    Rev Bras Pesqui Med Biol; 1973; 6(5):241-4. PubMed ID: 4521235
    [No Abstract]   [Full Text] [Related]  

  • 15. [Asparaginase].
    Boiron M; Jacquillat C; Weil M; Tanzer J; Bernard J
    Presse Med (1893); 1968 Nov; 76(44):2099-101. PubMed ID: 4882819
    [No Abstract]   [Full Text] [Related]  

  • 16. Asparaginase in acute leukaemia.
    Colebatch JH; Matthews RN; Gordon PM; Tan CL; Santamaria JN; Lay HN
    Med J Aust; 1970 Feb; 1(6):282. PubMed ID: 5266297
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical experience with L-asparaginase.
    Carbone PP; Haskell CM; Leventhal BG; Block JB; Selawry OS
    Recent Results Cancer Res; 1970; 33():236-43. PubMed ID: 4949163
    [No Abstract]   [Full Text] [Related]  

  • 18. Depression of functional and antigenic plasma antithrombin III (AT-III) due to therapy with L-asparaginase.
    Liebman HA; Wada JK; Patch MJ; McGehee W
    Cancer; 1982 Aug; 50(3):451-6. PubMed ID: 7046902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Asparaginase, leukemia and cancer].
    Levy D; Boiron M
    Bull Cancer; 1969; 56(4):365-74. PubMed ID: 4928248
    [No Abstract]   [Full Text] [Related]  

  • 20. L-asparaginase: clinical, biochemical, pharmacological, and immunological studies.
    Capizzi RL; Bertino JR; Skeel RT; Creasey WA; Zanes R; Olayon C; Peterson RG; Handschumacher RE
    Ann Intern Med; 1971 Jun; 74(6):893-901. PubMed ID: 5281051
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.